Protocol of investigation into reporting quality of RCT abstracts on COVID-19 pursuant to CONSORT (CoCo study)-a review

被引:0
|
作者
Tulka, Sabrina [1 ]
Baulig, Christine [1 ]
Knippschild, Stephanie [1 ]
机构
[1] Witten Herdecke Univ, Fac Hlth, Chair Med Biometry & Epidemiol IMBE, Alfred Herrhausen Str 50, D-58448 Witten, Germany
关键词
COVID-19; CONSORT; Reporting quality; RCT; Transparency; Coronavirus; SARS-CoV-2;
D O I
10.1186/s13063-021-05937-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background In 2020, the COVID-19 pandemic developed into a global crisis, the enormity and urgency of which accelerated research activities in the field. At the same time, manuscripts describing these research projects underwent fast-track peer review procedures and were published in freely accessible formats. Although full texts about COVID-19 are currently available for free, abstracts continue to play a key role since they provide essential information and possibly a decision basis for therapies. Abstracts are particularly important in case the full texts are not free, not all reports have been published in English and in emergency situations when there is less time for comprehensive analysis of all full texts. It is therefore necessary to ensure that abstracts-as publications in miniature format-contain comprehensive and transparent information. The CONSORT statement for abstracts (CONSORT-A) offers guidelines to authors how to include all necessary information in an abstract. Prior to the COVID-19 pandemic, the quality of reporting in medical research had already been the object of debate and criticism. The current crisis makes comprehensive documentation all the more important. Abstracts of COVID-19 RCTs should therefore report the criteria listed in the CONSORT-A statement fully and verifiably. The objective of this study is to check the completeness of abstracts of all COVID-19 RTCs published to date. Methods Based on a literature search in PubMed, Embase and the Cochrane Library, all publications up to 29 October 2020 are identified and examined in terms of the subject matter (reported results from COVID-19 studies) and their study design (RTC). Subsequently, suitable publications are examined for completeness and quality of abstracts. The CONSORT checklist for RTC abstracts serves as a basis in this procedure. The primary endpoint of the study is the percentage of correctly implemented items of the CONSORT statement for abstracts. The frequency of correct reporting of each individual item is checked in a second step. Discussion The study is expected to contribute to evaluating the reporting quality on COVID-19 studies, and specifically the completeness of abstracts of RTCs. It may thus support the assessment of current research into COVID-19.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Protocol of investigation into reporting quality of RCT abstracts on COVID-19 pursuant to CONSORT (CoCo study)—a review
    Sabrina Tulka
    Christine Baulig
    Stephanie Knippschild
    Trials, 22
  • [2] Evaluation of reporting quality of abstracts of randomized controlled trials regarding patients with COVID-19 using the CONSORT statement for abstracts
    Yin, Yuhuan
    Gao, Jiangxia
    Zhang, Yiyin
    Zhang, Xiaoli
    Ye, Jianying
    Zhang, Juxia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : 122 - 129
  • [3] Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review
    Yuniar, Cindra Tri
    Pratiwi, Bhekti
    Ihsan, Ardika Fajrul
    Laksono, Bambang Tri
    Risfayanti, Iffa
    Fathadina, Annisa
    Jeong, Yeonseon
    Kim, Eunyoung
    VACCINES, 2022, 10 (02)
  • [4] Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic review
    Zhang, Guanran
    Kuang, Sirui
    Zhang, Xiaoli
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [5] Methodological quality and reporting quality of COVID-19 living systematic review: a cross-sectional study
    Jiefeng Luo
    Zhe Chen
    Dan Liu
    Hailong Li
    Siyi He
    Linan Zeng
    Mengting Yang
    Zheng Liu
    Xue Xiao
    Lingli Zhang
    BMC Medical Research Methodology, 23
  • [6] Methodological quality and reporting quality of COVID-19 living systematic review: a cross-sectional study
    Luo, Jiefeng
    Chen, Zhe
    Liu, Dan
    Li, Hailong
    He, Siyi
    Zeng, Linan
    Yang, Mengting
    Liu, Zheng
    Xiao, Xue
    Zhang, Lingli
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [7] Disparity in the quality of COVID-19 data reporting across India
    Varun Vasudevan
    Abeynaya Gnanasekaran
    Varsha Sankar
    Siddarth A. Vasudevan
    James Zou
    BMC Public Health, 21
  • [8] Disparity in the quality of COVID-19 data reporting across India
    Vasudevan, Varun
    Gnanasekaran, Abeynaya
    Sankar, Varsha
    Vasudevan, Siddarth A.
    Zou, James
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [9] COVID-19: A review of therapeutics under investigation
    Crosby, James C.
    Heimann, Matthew A.
    Burleson, Samuel L.
    Anzalone, Brendan C.
    Swanson, Jonathan F.
    Wallace, Douglas W.
    Greene, Christopher J.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2020, 1 (03) : 231 - 237
  • [10] Abstracts for reports of randomized trials of COVID-19 interventions had low quality and high spin
    Wang, Dongguang
    Chen, Lingmin
    Wang, Lian
    Hua, Fang
    Li, Juan
    Li, Yuxi
    Zhang, Yonggang
    Fan, Hong
    Li, Weimin
    Clarke, Mike
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2021, 139 : 107 - 120